XNAS: GALT
Galectin Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...
Read More
4.16
-0.06
(-1.42%)
312.1K
XNAS Volume
XNAS 17 Jul, 2026 3:09 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Galectin Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..